CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Related Content
Support Our ‘Put Kids First’ Campaign Launch
Access the tools you need to amplify Children's Hospital Association's message and elevate children's health to where it belongs.
CHA Launches New Campaign to ‘Put Kids First’ in Health Care Policy
The digital campaign advocates for robust federal funding for children’s health.
A New Blueprint for a Resilient Pediatric Supply Chain
An unprecedented pilot public-private collaboration shows promise in mitigating drug shortages.